相似文献
1
Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database.
JAMA Intern Med. 2021 Sep 1;181(9):1243-1245. doi: 10.1001/jamainternmed.2021.2219.
2
Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
J Peripher Nerv Syst. 2022 Sep;27(3):206-214. doi: 10.1111/jns.12507. Epub 2022 Jul 6.
3
Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023: A comprehensive analysis of the international pharmacovigilance database.
J Med Virol. 2024 Jul;96(7):e29792. doi: 10.1002/jmv.29792.
4
Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database.
Clin Drug Investig. 2020 Sep;40(9):883-889. doi: 10.1007/s40261-020-00952-0.
5
Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database.
J Med Virol. 2024 Jun;96(6):e29682. doi: 10.1002/jmv.29682.
6
Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database.
J Med Virol. 2024 Jun;96(6):e29693. doi: 10.1002/jmv.29693.
7
Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database.
J Med Virol. 2022 Mar;94(3):1085-1095. doi: 10.1002/jmv.27424. Epub 2021 Nov 8.
8
A disproportionality analysis for the association of central nervous system demyelinating diseases with COVID-19 vaccination using the World Health Organization pharmacovigilance database.
Mult Scler. 2022 Nov;28(13):2112-2123. doi: 10.1177/13524585221109397. Epub 2022 Jul 13.
9
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France.
Drug Saf. 2023 Dec;46(12):1381-1389. doi: 10.1007/s40264-023-01359-4. Epub 2023 Nov 5.
10
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.
Drug Saf. 2021 Jan;44(1):1-5. doi: 10.1007/s40264-020-01018-y. Epub 2020 Nov 21.
引用本文的文献
1
Disproportionality analysis of drug-induced erectile dysfunction using FAERS database.
Sci Rep. 2025 May 6;15(1):15760. doi: 10.1038/s41598-025-00231-y.
2
AS03-adjuvanted H5N1 vaccine enhances immune response by modulating NR4A1, SDC1, ID3 genes, and reducing cortisol.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2426319. doi: 10.1080/21645515.2024.2426319. Epub 2024 Nov 21.
3
Lower Motor Neuron Facial Palsy Following COVID-19 Infection and COVID-19 AZD1222 Vaxzervria (AstraZeneca) Vaccine Administration: Two Case Reports.
Int Med Case Rep J. 2024 Mar 23;17:215-219. doi: 10.2147/IMCRJ.S453158. eCollection 2024.
4
Adverse Events Following COVID-19 Vaccination in Adolescents: Insights From Pharmacovigilance Study of VigiBase.
J Korean Med Sci. 2024 Mar 4;39(8):e76. doi: 10.3346/jkms.2024.39.e76.
5
Understanding Sociodemographic Factors and Reasons Associated with COVID-19 Vaccination Hesitance among Adults in Tanzania: A Mixed-Method Approach.
Am J Trop Med Hyg. 2023 Sep 11;109(4):895-907. doi: 10.4269/ajtmh.23-0229. Print 2023 Oct 4.
6
Sudden sensorineural hearing loss after receiving an inactivated viral vaccine, Sinopharm: Two-case report.
SAGE Open Med Case Rep. 2023 Aug 10;11:2050313X231191237. doi: 10.1177/2050313X231191237. eCollection 2023.
7
Neurological Disorders following COVID-19 Vaccination.
Vaccines (Basel). 2023 Jun 19;11(6):1114. doi: 10.3390/vaccines11061114.
8
Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study.
Vaccines (Basel). 2023 Jan 22;11(2):247. doi: 10.3390/vaccines11020247.
9
Bell's Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
Vaccines (Basel). 2023 Jan 20;11(2):236. doi: 10.3390/vaccines11020236.
10
Concurrent facial and trigeminal nerve palsies in a child following COVID-19 vaccination with the Pfizer vaccine.
BMJ Case Rep. 2023 Jan 30;16(1):e253302. doi: 10.1136/bcr-2022-253302.
Zotero 插件